Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Hemorrhoids Market Forecast Highlighting Growth From $3.11 Billion To $3.96 Billion

The market for hemorrhoid treatments has experienced robust expansion lately, moving from $2.93 billion in 2025 to $3.11 billion in 2026 with a compound annual growth rate of 6.4%. Factors contributing to this expansion throughout the past period include the growing popularity of inactive lifestyles, a rise in chronic constipation cases, heightened consciousness about conditions affecting the anus and rectum, the proliferation of outpatient care options, and the availability of diverse therapeutic interventions.

The global hemorrhoid treatment market is projected for significant expansion, anticipating a surge to $3.96 billion by 2030, fueled by a compound annual growth rate (CAGR) of 6.2%. This upward trajectory is underpinned by several key factors, including a steadily increasing elderly demographic, heightened emphasis on prompt diagnosis and intervention, burgeoning demand for less invasive surgical options, the expanding reach of telehealth for proctological consultations, and the wider availability of sophisticated therapeutic approaches. Within this period, prominent market shifts are expected to encompass a greater embrace of minimally invasive hemorrhoid therapies, a rise in the uptake of over-the-counter remedies, increased utilization of non-surgical interventions, the proliferation of home-based management strategies, and a heightened focus on patient comfort and recuperation.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22000&type=smp

Hemorrhoids Market Growth Factors Supporting Long-Term Expansion

The hemorrhoids market is poised for expansion, primarily fueled by escalating healthcare spending. This increased financial investment in health, encompassing outlays by individuals, institutions, and governments towards health upkeep, prevention, and management, is a significant market driver. The upward trend in health expenditures can be attributed to the continuous evolution of medical technology; novel diagnostic methods, therapeutic interventions, and groundbreaking treatments inherently carry substantial costs, thereby elevating overall healthcare spending. Furthermore, augmented healthcare budgets facilitate broader access to medical treatments, prophylactic measures, pharmaceuticals, and sophisticated procedures, ultimately benefiting the management and prognosis of hemorrhoidal conditions. To illustrate, data from the Centers for Medicare & Medicaid Services, a U.S. entity overseeing Medicare and Medicaid, revealed that in 2023, American healthcare expenditures saw a 7.5% surge, reaching $4.9 trillion, which translates to approximately $14,570 per capita. Consequently, this upward trajectory in healthcare expenditure is instrumental in advancing the hemorrhoids market.

Hemorrhoids Market Segment Breakdown: Which Categories Generate The Most Revenue?

The hemorrhoids market covered in this report is segmented –

1) By Type: Internal Hemorrhoids, External Hemorrhoids, Mixed Hemorrhoids

2) By Treatment Type: Medications, Procedures And Surgical Treatments

3) By End User: Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), Homecare

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Internal Hemorrhoids: Grade I, Grade II, Grade III, Grade IV

2) By External Hemorrhoids: Thrombosed External Hemorrhoids, Non-Thrombosed External Hemorrhoids

3) By Mixed Hemorrhoids: Combined Internal And External Hemorrhoids, Prolapsed Hemorrhoids

Hemorrhoids Market Industry Trends Shaping Future Revenue Growth

Companies at the forefront of the hemorrhoid sector are actively pursuing the creation of novel surgical interventions, specifically focusing on minimally invasive approaches to alleviate patient discomfort, expedite recovery periods, and elevate clinical results. Such minimally invasive techniques employ sophisticated medical procedures aimed at minimizing tissue trauma, diminishing post-operative pain, and shortening recuperation phases when contrasted with conventional hemorrhoid removal surgeries. Illustrating this trend, in December of 2023, Medical Fintech Innovations B.V., a Dutch entity specializing in technological advancements, unveiled the HemWell GEN 2. This latest iteration of their device incorporates the pioneering Hemwellectomy approach, a minimally invasive electrosurgical method for addressing hemorrhoid conditions. This cutting-edge methodology is engineered to provide individuals undergoing treatment with a less painful option compared to standard hemorrhoidectomy procedures, thereby fostering accelerated healing and facilitating a prompt resumption of everyday routines.

Hemorrhoids Market Key Players And Strategic Industry Positioning

Major companies operating in the hemorrhoids market are Johnson & Johnson, Bayer AG, Abbott Laboratories, Medtronic Plc, Takeda Pharmaceutical Company, Boston Scientific Corporation, Church & Dwight Co. Inc., Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals, B. Braun Melsungen AG, Sebela Pharmaceuticals, Citius Pharmaceuticals, AMATO PHARMACEUTICAL PRODUCTS LTD, Surkon Medical Co. Ltd., Privi Medical, CONMED Corporation, Integra LifeSciences Corporation, Takeda Consumer Healthcare, Fresenius Kabi, Sanofi

Access The Complete Hemorrhoids Market Report:

https://www.thebusinessresearchcompany.com/report/hemorrhoids-global-market-report

Hemorrhoids Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the hemorrhoids market in 2025. The regions covered in the hemorrhoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model